|Bid||0.082 x 0|
|Ask||0.100 x 0|
|Day's Range||0.096 - 0.102|
|52 Week Range||0.080 - 0.176|
|Beta (3Y Monthly)||0.81|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Nov 1 (Reuters) - China Health Group Ltd: * COMPANY ENTERED INTO STRATEGIC COOPERATION AGREEMENT WITH HUNAN JUNLIN IN RELATION TO FORMATION OF FUND * INTENDS TO INVEST NOT MORE THAN RMB25 MILLION TO FUND ...
Every investor in China Health Group Limited (HKG:673) should be aware of the most powerful shareholder groups. Generally speaking, as a company grows, institutions will increase their ownership. Conversely, insidersRead More...
July 13 (Reuters) - China Health Group Ltd: * WANG YONGQING RESIGNED AS AN EXECUTIVE DIRECTOR Source text for Eikon: Further company coverage:
June 29 (Reuters) - China Health Group Ltd: * LOSS FOR YEAR HK$39.2 MILLION VERSUS LOSS HK$69.3 MILLION * FY REVENUE HK$24.2 MILLION VERSUS HK$15 MILLION Source text for Eikon: Further company coverage:...
March 26 (Reuters) - China Health Group Ltd: * CO, BEIKE RONGHUI LIFE TECHNOLOGY & RONGHUI RENHE INVESTMENT MANAGEMENT ENTERED AGREEMENT TO DEVELOP RESEARCH CENTRE Source text for Eikon: Further company ...